Lars Olsen has more than 20 years of experience from operations and project execution within the pharma, biotech and medical device industries.
His primary focus is on packaging and counterfeit studies, and he is a leading expert in pharmaceutical packaging processes. He is involved in projects for pharmaceutical companies worldwide within packaging processes, counterfeit, assembly and medical devices.
Lars Olsen has been a steering committee member of the ISPE society since 2005 and Facilitator of ISPE COP for Pharmaceutical Packaging. With a background in machine construction engineering and years of manufacturing experience, he bridges the gap between design and execution, applied in numerous conceptual design and optimisation assignments. Furthermore, his broad experience has given him a unique ability to align engineering solutions with overall efficiency and performance goals. He is an experienced user representative and process responsible with a strong focus on optimal solutions for a well-running production.
The biggest challenge of serialization today is to make all ends meet without negatively influencing capacity.
What’s your view on the industry?
“The biggest challenge of serialization today is making all ends meet without negatively influencing capacity. In the world of tomorrow, where patient centric strategies meet modern codification and tracking requirements, there is a high risk of efficiency decrease if you don’t make a thorough plan. A successful plan balances CAPEX with OPEX and good business cases that justify investments. While the major pharmaceutical companies are already at the forefront and have contributed to the development of international guidelines, many small and mid-sized companies fail to deal with the problem in time”
Why work in this industry?
"I had my first encounter with fraud on my very first job: our otherwise good single-use medical devices were being reused at certain hospitals, which practiced “garbage can diving”. Used infusion sets and IV cannulas were picked up, cleaned with tap water and reintroduced in the supply chain. Reading the complaints we received and learning the consequences for the people infected by these non-sterile devices made me angry and sad. Since then, awareness and interest in counterfeit (and especially on the anti-counterfeit means) have followed me throughout my 25 years in pharmaceutical packaging. In my current job I feel that I can make a difference – not only for my customers but also for the end-user."
Connect on LinkedIn